Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomasFelipe C. Geyer(Memorial Sloan Kettering Cancer Center), Jorge S. Reis‐Filho(Memorial Sloan Kettering Cancer Center)Nature CommunicationsMay 1, 201810.1038/s41467-018-04128-5Cited by 138SaveCiteExport RISWatch citationsRelated PapersIntra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification|Genome Biology|2015|135Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer|Oncotarget|2016|15